| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
OrthoPediatrics (NASDAQ:KIDS) reported its Q4 earnings results on Wednesday, March 6, 2024 at 04:05 PM.
Here's what investors need to know about the announcement.
OrthoPediatrics beat estimated earnings by 18.0%, reporting an EPS of $-0.23 versus an estimate of $-0.28.
Revenue was up $6.62 million from the same period last year.
Last quarter the company beat on EPS by $0.09 which was followed by a 2.0% increase in the share price the next day.
Here's a look at OrthoPediatrics's past performance:
| Quarter | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|
| EPS Estimate | -0.22 | -0.19 | -0.36 | -0.25 |
| EPS Actual | -0.13 | -0.19 | -0.29 | -0.32 |
| Revenue Estimate | 40.37M | 39.11M | 29.30M | 32.62M |
| Revenue Actual | 39.97M | 39.56M | 31.59M | 30.99M |
To track all earnings releases for OrthoPediatrics visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Posted In: KIDS
